Averna's Matt Thompson shares strategies to avoid common traps when transitioning medical devices from R&D to manufacturing.

Type 1 diabetes is an autoimmune disease in which the insulin-producing β cells in the pancreatic islets of Langerhans are ...

Management is increasing investments in the Products segment to reduce reliance on third-party distribution and enhance growth predictability.

The management of rheumatoid arthritis (RA) has significantly improved, but a substantial number of patients still experience persistent disease activity, leading to the concept of ‘difficult-to-treat ...

Effective monitoring of development aid is the foundation for assessing the alignment of flows with their intended ...